Cocaine nasal spray approved by the FDA
Medical cocaine has been around since it was synthesized at the end of the 19th century. Used at the time as an anaesthetic, it was also recommended for treating respiratory diseases. Its use declined with the advent of modern anesthetics and its classification as a narcotic under the 1961 UN Convention.
In mid-January, however, the FDA approved a cocaine hydrochloride nasal spray, dubbed Numbrino, after two randomized, double-blind Phase III clinical trials.
«FDA approval of our cocaine product, the first to include full clinical trials in the company's history, marks an important milestone in Lannett's 70-year history,» said Tim Crew, CEO of Lannett Company, in an press release. «We believe the product has the potential to be an excellent option for its indication. We plan to launch the product shortly...».
Unlike the Cannabis, classified in Schedule I of the Narcotics Control List, the most restrictive, cocaine has been placed in Schedule II, in recognition of the fact that it can be used for medical purposes.
The administration of pharmaceutical cocaine via the nasal route has already been tested in the USA. In the 1980s, Los Angeles-based researcher Ronald K. Siegel studied the effects of cocaine on arthritis pain. The study showed that cocaine could effectively manage chronic pain without triggering an addictive effect. However, patients reported feeling uncomfortable «hitting» a drug, and some study subjects turned to non-pharmaceutical cocaine after Siegel revealed the drug's true identity.
Nasal sprays are particularly used for medical purposes. Last year, President Trump asked the U.S. Department of Veterans Affairs to purchase an FDA-approved ketamine nasal spray (from Johnson & Johnson) to treat depression in veterans. In December, an Oregon-based company announced that she would start developing a nasal spray to administer psilocybin, the psychedelic component of mushrooms.
Nasal sprays for cannabis have already been in existence for several years, but none are FDA-approved.
-
Business2 weeks ago
New York Opens Its Farmers' Markets to Small-Scale Cannabis Producers
-
Cannabis in France3 weeks ago
French Polynesia Is Finally Ready to Launch Its «Medical Cannabis» Pilot Program After Months of Delays
-
Cannabis in Nepal3 weeks ago
A Nepalese province legalizes medical cannabis
-
Cannabis in California3 weeks ago
Eight years after legalization, cannabis use in California has not increased
-
Cannabis in India2 weeks ago
India Approves a Synthetic CBD Drug for Anxiety
-
Cannabis in Africa2 weeks ago
Rwanda: A New License Revives the Country's Ambitions in Medical Cannabis
-
Cannabis in Europe2 weeks ago
The EU Simplifies Regulations Governing Hemp Cultivation
-
Cannabis in Canada3 weeks ago
Quick Hit July 2026: What We Missed in Recent Weeks


You must be logged in to post a comment Login